Call us : 1800 103 7100
Mail us : info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

Know More
24Oct/11

Beavis, Butt-Head bringing stupid back – Daily Comet

October 24, 2011Brain Death Declarationadmin

Beavis, Butt-Head bringing stupid backDaily CometAfter 14 years in retirement — or perhaps misdiagnosed brain death — the animated, teenage couch potatoes return, no wiser for the wear, to a new generation and a world of YouTube, mixed martial arts…

24Oct/11

Earnings Watch: Bristol-Myers Squibb is Scheduled to Report its Quarterly … – Financial News Network Online

October 24, 2011Transplant Rejectionadmin

Earnings Watch: Bristol-Myers Squibb is Scheduled to Report its Quarterly …Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ tr…

24Oct/11

UNITED STATES : IncellDx CEO Applauds New Cancer Screening Recommendations – BioOptics World

October 24, 2011Transplant Rejectionadmin

UNITED STATES : IncellDx CEO Applauds New Cancer Screening RecommendationsBioOptics WorldIncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervical cancer, breast cancer, HI…

24Oct/11

Three-drug Regimen for Idiopathic Pulmonary Fibrosis Found Harmful – Kansas City infoZine

October 24, 2011Immunosuppressive Drugsadmin

Three-drug Regimen for Idiopathic Pulmonary Fibrosis Found HarmfulKansas City infoZineThe trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outco…

24Oct/11

Abbott, Biogen report MS drug reduced relapse rate – Boston.com

October 24, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Abbott, Biogen report MS drug reduced relapse rateBoston.comBiogen Idec and Abbott Laboratories said Sunday a mid-stage study of their multiple sclerosis medicine daclizumab showed that the experimental drug worked better than placebo at preventing rel…

24Oct/11

Technology Connects Stroke Experts With Patients in Ozarks – OzarksFirst.com

October 24, 2011Brain Death Declarationadmin

Technology Connects Stroke Experts With Patients in OzarksOzarksFirst.com"The further you wait the more brain damage, brain death that you can incur," notes Carol Beal, Stroke Program Director at St. John's Regional Health System. "T…

24Oct/11

Blood Donation Levels Decline in Detroit, Red Cross Struggling for New Donations – ThirdAge

October 24, 2011Organ Donoradmin

ThirdAgeBlood Donation Levels Decline in Detroit, Red Cross Struggling for New DonationsThirdAgeBlood donations in the Detroit area are down by about three percent, The Detroit News reports. The decline came at a time when contributions were expected t…

24Oct/11

Stocks to watch Monday: Mattel, Biogen Idec – MarketWatch

October 24, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Stocks to watch Monday: Mattel, Biogen IdecMarketWatchMore good news for Biogen Idec Inc.: The company and Abbott Laboratories Inc. /quotes/zigman/216393/quotes/nls/abt ABT -0.76% on Saturday presented positive data from a trial to evaluate an investig…

24Oct/11

A look at the hype behind Omega-3s – SILive.com

October 24, 2011Transplant Rejectionadmin

A look at the hype behind Omega-3sSILive.com… colon cancer, ulcerative colitis, Crohn's Disease, IgA nephropathy, psoriasis, eczema, asthma, preeclampsia, schizophrenia, bipolar disorder, depression, dysmennorhea, cystic fibrosis, diabetes, hyper…

24Oct/11

Biogen jumps on strong MS drug data: Sanofi's Lemtrada significant improvement … – The Pharma Letter

October 24, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Biogen jumps on strong MS drug data: Sanofi's Lemtrada significant improvement …The Pharma LetterBiogen and partner Abbott Laboratories (NYSE: ABT) also announced additional results from the SELECT Phase IIb trial, the first of two registrational…

Posts navigation

  • « Previous
  • 1
  • …
  • 15,972
  • 15,973
  • 15,974
  • 15,975
  • 15,976
  • …
  • 16,126
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Hosted and managed by www.medindindia.net